In this study the investigators aim to compare the efficacy of neomycin to a combination of rifaximin and neomycin in the treatment of C-IBS subjects with methane on their breath test. This study will be conducted in collaboration with Dr. John DiBaise at the Mayo Clinic in Scottsdale, AZ and Dr. Satish Rao in Georgia Regents University in Augusta, GA.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
37
Cedars-Sinai Medical Center
Los Angeles, California, United States
Georgia Health Sciences University
Augusta, Georgia, United States
Severity of Constipation in Each Arm at Week 1 After Completion of Therapy
Visual analog scale (VAS) score for constipation: Severity was rated using a VAS from 0 to 100 units (with 0 = no symptom and 100 = severe symptoms).
Time frame: 1 year
Change in Methane From Baseline
Methane output was reported as methane in parts per million (ppm) on breath test: Subjects fast for 12 h prior to a breath sample. Breath samples were collected via a Quintron dual bag collecting system and analyzed using a BreathTracker SC. Output was reported as methane in parts per million (ppm) after correction for alveolar sample quality using breath CO2 concentration.
Time frame: Baseline (Day 0) and Final Visit (Day 44)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.